A double blind, placebo-controlled randomized trial of low-dose risperidone, intensive psychological treatment and supportive therapy in young people with subthreshold symptoms at incipient risk of psychotic disorder: baseline characteristics of the sample
Version 2 2024-06-05, 11:35Version 2 2024-06-05, 11:35
Version 1 2021-05-12, 15:35Version 1 2021-05-12, 15:35
conference contribution
posted on 2024-06-05, 11:35authored byB Nelson, LJ Phillips, Alison YungAlison Yung, SM Francey, S Leicester, K Baker, H Krstev, P Amminger, G Berger, I DiBella, A Thampi, D McGorry
A double blind, placebo-controlled randomized trial of low-dose risperidone, intensive psychological treatment and supportive therapy in young people with subthreshold symptoms at incipient risk of psychotic disorder: baseline characteristics of the sample